Zinc Acetate

CHEMBL3184986 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
183.5 g/mol
LogP
Phase
4

Zinc acetate is a zinc salt used therapeutically for Wilson's disease, a copper metabolism disorder, where orally administered zinc ions competitively inhibit intestinal copper absorption by inducing enterocyte metallothionein that sequesters copper and prevents its transfer to portal blood. It is also used as a dietary zinc supplement to treat or prevent zinc deficiency, supporting immune function, wound healing, and neurological function. Zinc acetate is preferred for maintenance therapy of Wilson's disease due to its favorable safety profile.

分子量

183.5000 g/mol

TPSA

80.30 Ų

治疗领域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)[O-].CC(=O)[O-].O.O.[Zn+2]

InChI

InChI=1S/2C2H4O2.2H2O.Zn/c2*1-2(3)4;;;/h2*1H3,(H,3,4);2*1H2;/q;;;;+2/p-2

Molecular Formula

C4H6O4Zn

HBD / HBA

- / 4

可旋转键数

0

重原子数

9

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

Zinc acetate is a zinc salt used therapeutically for Wilson's disease, a copper metabolism disorder, where orally administered zinc ions competitively inhibit intestinal copper absorption by inducing enterocyte metallothionein that sequesters copper and prevents its transfer to portal blood. It is also used as a dietary zinc supplement to treat or prevent zinc deficiency, supporting immune function, wound healing, and neurological function. Zinc acetate is preferred for maintenance therapy of Wilson's disease due to its favorable safety profile.

Yes, Zinc Acetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3184986. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 11192. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.